Please enable JavaScript to continue using this application.

Compare $ALMR vs $PACB | Chartloom

Compare

$ALMR vs $PACB

Alamar Biosciences Inc · Pacific Biosciences of California Inc

ALMR

Alamar Biosciences Inc

PACB

Pacific Biosciences of California Inc

Compare $ALMR vs $PACB

Comparing Alamar Biosciences Inc and Pacific Biosciences of California Inc

ALMRAlamar Biosciences Inc

PACBPacific Biosciences of California Inc

ALMRAlamar Biosciences Inc

Market cap

$1.75B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

12.35x

Rev growth (TTM)

—

YTD performance

14.9%

52W performance

14.9%

FCF yield

0.0%

PACBPacific Biosciences of California Inc

Market cap

$724M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.11x

Rev growth (TTM)

2.0%

YTD performance

26.6%

52W performance

54.3%

FCF yield

-18.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALMR

PACB

Detailed metrics comparison

ALMR

Alamar Biosciences Inc

PACB

Pacific Biosciences of California Inc

Market Cap

ALMR$1.75B

PACB$724M

Enterprise Value

ALMR$1.63B

PACB$1.31B

Price

ALMR$25.27

PACB$2.33

P/E Ratio

ALMRN/A

PACBN/A

P/S Ratio

ALMR31.58x

PACB4.54x

EV/Sales

ALMR29.36x

PACB8.21x

EV/EBITDA

ALMR0.00x

PACB40.33x

P/B Ratio

ALMR7.62x

PACB333.69x

P/FCF Ratio

ALMRN/A

PACBN/A

EV/FCF

ALMR0.00x

PACB-10.00x

PEG Ratio

ALMRN/A

PACBN/A

Forward P/E (NTM)

ALMRN/A

PACBN/A

Forward P/S (NTM)

ALMR12.35x

PACB4.11x

Revenue (TTM)

ALMR$55M

PACB$159M

Revenue Growth (YoY)

ALMRN/A

PACB2.0%

Forward Rev Growth

ALMR39.6%

PACB15.4%

Gross Margin (TTM)

ALMR58.0%

PACB39.2%

Operating Margin (TTM)

ALMR0.0%

PACB0.0%

EBITDA Margin (TTM)

ALMR-45.8%

PACB-88.6%

Net Margin (TTM)

ALMR-62.2%

PACB-82.5%

FCF Margin (TTM)

ALMR0.0%

PACB-82.0%

Net Income (TTM)

ALMR$-35M

PACB$-131M

FCF (TTM)

ALMR$0

PACB$-131M

EPS (TTM)

ALMR-$0.50

PACB-$0.42

ROE (TTM)

ALMR0.0%

PACB-48845.0%

ROA (TTM)

ALMR0.0%

PACB-1684.0%

ROIC (TTM)

ALMR0.0%

PACB-1914.0%

Cash

ALMR$133M

PACB$61M

Debt

ALMR$10M

PACB$644M

Net Cash/Debt

ALMR$123M

PACB$-583M

Current Ratio (TTM)

ALMR11.85x

PACB4.92x

Quick Ratio (TTM)

ALMR9.67x

PACB3.90x

Debt/Equity (TTM)

ALMR0.03x

PACB272.23x

Debt/Assets (TTM)

ALMR0.0%

PACB0.0%

Interest Coverage (TTM)

ALMRN/A

PACBN/A

Net Debt/EBITDA (TTM)

ALMR0.00x

PACB0.00x

Beta

ALMR-0.30

PACB2.25

52W Performance

ALMR14.9%

PACB54.3%

YTD Performance

ALMR14.9%

PACB26.6%

% from 52W High

ALMR-36.2%

PACB-32.2%

% from 52W Low

ALMR34.1%

PACB117.8%

Asset Turnover (TTM)

ALMR0.00x

PACB0.20x

FCF Yield (TTM)

ALMR0.0%

PACB-18.1%

Earnings Yield (TTM)

ALMR-2.0%

PACB-18.2%

Dividend Yield (TTM)

ALMRN/A

PACBN/A

Rule of 40

ALMR0.0

PACB-80.0

EV/GP/RG

ALMR0.30

PACB1.70

Ticker research

View ALMR research View PACB research

Metric	ALMR Alamar Biosciences Inc	PACB Pacific Biosciences of California Inc
Market & Valuation
Market Cap	$1.75B	$724M
Enterprise Value	$1.63B	$1.31B
Price	$25.27	$2.33
P/E Ratio	N/A	N/A
P/S Ratio	31.58x	4.54x
EV/Sales	29.36x	8.21x
EV/EBITDA	0.00x	40.33x
P/B Ratio	7.62x	333.69x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-10.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.35x	4.11x
Revenue & Growth
Revenue (TTM)	$55M	$159M
Revenue Growth (YoY)	N/A	2.0%
Forward Rev Growth	39.6%	15.4%
Profitability
Gross Margin (TTM)	58.0%	39.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-45.8%	-88.6%
Net Margin (TTM)	-62.2%	-82.5%
FCF Margin (TTM)	0.0%	-82.0%
Net Income (TTM)	$-35M	$-131M
FCF (TTM)	$0	$-131M
EPS (TTM)	-$0.50	-$0.42
ROE (TTM)	0.0%	-48845.0%
ROA (TTM)	0.0%	-1684.0%
ROIC (TTM)	0.0%	-1914.0%
Financial Health
Cash	$133M	$61M
Debt	$10M	$644M
Net Cash/Debt	$123M	$-583M
Current Ratio (TTM)	11.85x	4.92x
Quick Ratio (TTM)	9.67x	3.90x
Debt/Equity (TTM)	0.03x	272.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.30	2.25
52W Performance	14.9%	54.3%
YTD Performance	14.9%	26.6%
% from 52W High	-36.2%	-32.2%
% from 52W Low	34.1%	117.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.20x
FCF Yield (TTM)	0.0%	-18.1%
Earnings Yield (TTM)	-2.0%	-18.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-80.0
EV/GP/RG	0.30	1.70
Ticker research	View ALMR research	View PACB research

Valuation

P/S Ratio

PACB

4.54x

ALMR

31.58x

EV/FCF

PACB

-10.00x

ALMR

0.00x

Growth & revenue

Revenue Growth TTM

PACB

2.0%

Forward Revenue Growth

ALMR

39.6%

PACB

15.4%

Profitability & performance

Gross Margin

ALMR

58.0%

PACB

39.2%

ROE

ALMR

0.0%

PACB

-48845.0%

FCF Yield %

ALMR

0.0%

PACB

-18.1%

52-Week Performance

PACB

54.3%

ALMR

14.9%

Detailed metrics comparison

ALMR

Alamar Biosciences Inc

PACB

Pacific Biosciences of California Inc

Market Cap

ALMR$1.75B

PACB$724M

Enterprise Value

ALMR$1.63B

PACB$1.31B

Price

ALMR$25.27

PACB$2.33

P/E Ratio

ALMRN/A

PACBN/A

P/S Ratio

ALMR31.58x

PACB4.54x

EV/Sales

ALMR29.36x

PACB8.21x

EV/EBITDA

ALMR0.00x

PACB40.33x

P/B Ratio

ALMR7.62x

PACB333.69x

P/FCF Ratio

ALMRN/A

PACBN/A

EV/FCF

ALMR0.00x

PACB-10.00x

PEG Ratio

ALMRN/A

PACBN/A

Forward P/E (NTM)

ALMRN/A

PACBN/A

Forward P/S (NTM)

ALMR12.35x

PACB4.11x

Revenue (TTM)

ALMR$55M

PACB$159M

Revenue Growth (YoY)

ALMRN/A

PACB2.0%

Forward Rev Growth

ALMR39.6%

PACB15.4%

Gross Margin (TTM)

ALMR58.0%

PACB39.2%

Operating Margin (TTM)

ALMR0.0%

PACB0.0%

EBITDA Margin (TTM)

ALMR-45.8%

PACB-88.6%

Net Margin (TTM)

ALMR-62.2%

PACB-82.5%

FCF Margin (TTM)

ALMR0.0%

PACB-82.0%

Net Income (TTM)

ALMR$-35M

PACB$-131M

FCF (TTM)

ALMR$0

PACB$-131M

EPS (TTM)

ALMR-$0.50

PACB-$0.42

ROE (TTM)

ALMR0.0%

PACB-48845.0%

ROA (TTM)

ALMR0.0%

PACB-1684.0%

ROIC (TTM)

ALMR0.0%

PACB-1914.0%

Cash

ALMR$133M

PACB$61M

Debt

ALMR$10M

PACB$644M

Net Cash/Debt

ALMR$123M

PACB$-583M

Current Ratio (TTM)

ALMR11.85x

PACB4.92x

Quick Ratio (TTM)

ALMR9.67x

PACB3.90x

Debt/Equity (TTM)

ALMR0.03x

PACB272.23x

Debt/Assets (TTM)

ALMR0.0%

PACB0.0%

Interest Coverage (TTM)

ALMRN/A

PACBN/A

Net Debt/EBITDA (TTM)

ALMR0.00x

PACB0.00x

Beta

ALMR-0.30

PACB2.25

52W Performance

ALMR14.9%

PACB54.3%

YTD Performance

ALMR14.9%

PACB26.6%

% from 52W High

ALMR-36.2%

PACB-32.2%

% from 52W Low

ALMR34.1%

PACB117.8%

Asset Turnover (TTM)

ALMR0.00x

PACB0.20x

FCF Yield (TTM)

ALMR0.0%

PACB-18.1%

Earnings Yield (TTM)

ALMR-2.0%

PACB-18.2%

Dividend Yield (TTM)

ALMRN/A

PACBN/A

Rule of 40

ALMR0.0

PACB-80.0

EV/GP/RG

ALMR0.30

PACB1.70

Ticker research

View ALMR research View PACB research

Metric	ALMR Alamar Biosciences Inc	PACB Pacific Biosciences of California Inc
Market & Valuation
Market Cap	$1.75B	$724M
Enterprise Value	$1.63B	$1.31B
Price	$25.27	$2.33
P/E Ratio	N/A	N/A
P/S Ratio	31.58x	4.54x
EV/Sales	29.36x	8.21x
EV/EBITDA	0.00x	40.33x
P/B Ratio	7.62x	333.69x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-10.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.35x	4.11x
Revenue & Growth
Revenue (TTM)	$55M	$159M
Revenue Growth (YoY)	N/A	2.0%
Forward Rev Growth	39.6%	15.4%
Profitability
Gross Margin (TTM)	58.0%	39.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-45.8%	-88.6%
Net Margin (TTM)	-62.2%	-82.5%
FCF Margin (TTM)	0.0%	-82.0%
Net Income (TTM)	$-35M	$-131M
FCF (TTM)	$0	$-131M
EPS (TTM)	-$0.50	-$0.42
ROE (TTM)	0.0%	-48845.0%
ROA (TTM)	0.0%	-1684.0%
ROIC (TTM)	0.0%	-1914.0%
Financial Health
Cash	$133M	$61M
Debt	$10M	$644M
Net Cash/Debt	$123M	$-583M
Current Ratio (TTM)	11.85x	4.92x
Quick Ratio (TTM)	9.67x	3.90x
Debt/Equity (TTM)	0.03x	272.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.30	2.25
52W Performance	14.9%	54.3%
YTD Performance	14.9%	26.6%
% from 52W High	-36.2%	-32.2%
% from 52W Low	34.1%	117.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.20x
FCF Yield (TTM)	0.0%	-18.1%
Earnings Yield (TTM)	-2.0%	-18.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-80.0
EV/GP/RG	0.30	1.70
Ticker research	View ALMR research	View PACB research